Subtopic Deep Dive
Congenital Heart Disease in Pregnancy
Research Guide
What is Congenital Heart Disease in Pregnancy?
Congenital Heart Disease in Pregnancy refers to the management of maternal cardiovascular risks, fetal outcomes, and hemodynamic adaptations in women with pre-existing congenital heart defects during gestation.
Studies quantify maternal mortality risks from 1-50% across CHD subtypes, with highest rates in pulmonary hypertension and cyanotic lesions (Presbitero et al., 1994; Bédard et al., 2008). Registries report cardiac events in 10-15% of pregnancies and neonatal complications in 20-30% (Khairy et al., 2006; Roos-Hesselink et al., 2012). Over 20 key papers since 1994, including 10 with >400 citations each, establish risk stratification frameworks.
Why It Matters
Rising CHD survivorship into childbearing age increases pregnancy consultations, where counseling reduces maternal mortality from 50% in cyanotic cases to 5-10% with modern care (Presbitero et al., 1994; Bédard et al., 2008). Fetal risks like prematurity (20%) and low birth weight (15%) demand delivery planning (Khairy et al., 2006). Registries guide valve choice and PAH therapy, improving outcomes in 90% of low-risk CHD pregnancies (Roos-Hesselink et al., 2012).
Key Research Challenges
Risk Stratification Variability
Heterogeneity in CHD lesions leads to inconsistent risk prediction models across studies. Khairy et al. (2006) identified arrhythmias and heart failure in 14% of cases but noted gaps in subtype-specific predictors. Registry data show 25% cardiac event rate without unified scoring (Roos-Hesselink et al., 2012).
Pulmonary Hypertension Mortality
PAH in CHD carries 30-50% maternal mortality despite therapies. Bédard et al. (2008) reported progress from 50% to 17% mortality with multidisciplinary care. Optimal timing for termination counseling remains unresolved.
Fetal-Neonatal Complication Rates
Cyanotic CHD links to 46% miscarriage and 20% congenital malformations in offspring (Presbitero et al., 1994). Neonatal ICU admissions reach 30%, but long-term offspring cardiac risks lack prospective data (Khairy et al., 2006).
Essential Papers
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Shannon M. Bates, Ian A. Greer, Saskia Middeldorp et al. · 2012 · CHEST Journal · 1.5K citations
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Christina Chambers, Sonia Hernández–Dı́az, L.J. Van Marter et al. · 2006 · New England Journal of Medicine · 880 citations
These data support an association between the maternal use of SSRIs in late pregnancy and PPHN in the offspring; further study of this association is warranted. These findings should be taken into ...
Transposition of the Great Arteries
Carole A. Warnes · 2006 · Circulation · 692 citations
Many patients with ventriculoarterial discordance have survived to adulthood. Those with complete transposition of the great arteries have often had an atrial switch procedure (Mustard or Senning o...
Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?
É. Bédard, Konstantinos Dimopoulos, Michael Α. Gatzoulis · 2008 · European Heart Journal · 638 citations
Pregnancy in women with pulmonary arterial hypertension (PAH) is considered to be associated with prohibitive maternal mortality. During the past decade, new advanced therapies for PAH have emerged...
Ebstein’s Anomaly
Christine H. Attenhofer Jost, Heidi M. Connolly, Joseph A. Dearani et al. · 2007 · Circulation · 556 citations
Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus.
Patrizia Presbitero, Jane Somerville, Susan Stone et al. · 1994 · Circulation · 508 citations
In a series of 416 women with congenital heart disease seen in the Royal Brompton National Heart and Lung Hospital, London, and the Hospital Giovanni Bosco, Torino, Italy, there were 822 pregnancie...
Pregnancy Outcomes in Women With Congenital Heart Disease
Paul Khairy, David W. Ouyang, Susan M. Fernandes et al. · 2006 · Circulation · 493 citations
Background— Pregnant women with congenital heart disease are at increased risk for cardiac and neonatal complications, yet risk factors for adverse outcomes are not fully defined. Methods and Resul...
Reading Guide
Foundational Papers
Start with Presbitero et al. (1994) for cyanotic benchmarks (508 citations), then Khairy et al. (2006) for modern cohort risks (493 citations), and Bédard et al. (2008) for PAH evolution (638 citations).
Recent Advances
Roos-Hesselink et al. (2012, 446 citations) provides ROPAC registry outcomes; Bates et al. (2012, 1474 citations) covers antithrombotic strategies.
Core Methods
Prospective registries (ROPAC), hemodynamic modeling, WHO risk classification, multivariate regression for predictors (Khairy et al., 2006; Roos-Hesselink et al., 2012).
How PapersFlow Helps You Research Congenital Heart Disease in Pregnancy
Discover & Search
Research Agent uses searchPapers('Congenital Heart Disease pregnancy outcomes') to retrieve 20+ papers like Khairy et al. (2006, 493 citations), then citationGraph reveals clusters around PAH risks from Bédard et al. (2008). findSimilarPapers on Presbitero et al. (1994) surfaces cyanotic CHD studies; exaSearch queries 'CHD pregnancy registries' for ROPAC data.
Analyze & Verify
Analysis Agent applies readPaperContent to extract risk ratios from Roos-Hesselink et al. (2012), then verifyResponse with CoVe cross-checks mortality claims against Khairy et al. (2006). runPythonAnalysis computes meta-analysis odds ratios from 5 papers' event rates using pandas; GRADE grading scores Presbitero et al. (1994) as moderate evidence for cyanotic risks.
Synthesize & Write
Synthesis Agent detects gaps in mechanical valve anticoagulation via contradiction flagging across Bates et al. (2012) and Khairy et al. (2006); Writing Agent uses latexEditText for risk table, latexSyncCitations for 10-paper bibliography, and latexCompile for ESC guideline draft. exportMermaid generates CHD lesion outcome flowcharts.
Use Cases
"Extract and plot maternal mortality rates from cyanotic CHD pregnancy papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas plot of Presbitero 1994 + Bédard 2008 rates) → matplotlib survival curve output.
"Draft LaTeX review section on PAH in CHD pregnancy with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Bédard 2008, Roos-Hesselink 2012) → latexCompile → PDF guideline excerpt.
"Find code for CHD pregnancy risk calculators from papers"
Research Agent → paperExtractUrls (Khairy 2006) → paperFindGithubRepo → githubRepoInspect → R script for CARP-II score implementation.
Automated Workflows
Deep Research workflow scans 50+ CHD papers via searchPapers → citationGraph → structured ROPAC registry report with GRADE scores. DeepScan's 7-step chain verifies Bédard et al. (2008) PAH improvements against Khairy et al. (2006) via CoVe checkpoints. Theorizer generates hypotheses on valve thrombosis risks from Bates et al. (2012) + Presbitero et al. (1994).
Frequently Asked Questions
What defines Congenital Heart Disease in Pregnancy?
Management of pre-existing CHD defects like Ebstein’s anomaly or transposition during gestation, focusing on maternal cardiac events and fetal viability (Warnes, 2006; Attenhofer Jost et al., 2007).
What are key methods for risk assessment?
Multicenter registries like ROPAC stratify risks by lesion type; modified WHO classification predicts 5-50% event rates (Roos-Hesselink et al., 2012; Khairy et al., 2006).
What are seminal papers?
Presbitero et al. (1994, 508 citations) established cyanotic CHD risks; Khairy et al. (2006, 493 citations) quantified complications in 90 pregnancies; Bédard et al. (2008, 638 citations) tracked PAH outcomes.
What open problems persist?
Long-term offspring cardiac inheritance in CHD pregnancies lacks data; optimal anticoagulation for mechanical valves in high-risk cases unresolved (Bates et al., 2012; Presbitero et al., 1994).
Research Cardiovascular Issues in Pregnancy with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Congenital Heart Disease in Pregnancy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers